| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/22/2014 | CN103520739A Self-assembly compound system of cellulose nanometer fibril and indometacin and preparation method of self-assembly compound system |
| 01/22/2014 | CN103520736A Floxuridine-layered double hydroxide nanohybrid with polyethylene glycol derivative modified on surface and preparation thereof |
| 01/22/2014 | CN103520734A Albumin-based nano particle and preparation method and application thereof |
| 01/22/2014 | CN103520731A Folate-polyethylene glycol-polylactic acid segmented copolymer micelle encapsulated with hydrophobic anticancer drug and preparation method of segmented copolymer micelle |
| 01/22/2014 | CN103520730A Chitosan oligosaccharide nanoparticle capable of loading hydrophobic anti-tumor medicine |
| 01/22/2014 | CN103520728A Preparation method of arsenic trioxide invisible immunological targeting antitumor preparation |
| 01/22/2014 | CN103520726A Preparation method of invisible thermosensitive liposome as well as application of drug delivery system of invisible thermosensitive liposome in tumor treatment drugs |
| 01/22/2014 | CN103520723A Oxaliplatin medicinal composition and application thereof |
| 01/22/2014 | CN103520722A Application of miR-17-5p and miR-20a in preparation of etoposide drug-resistant reversal agent |
| 01/22/2014 | CN103520720A Preparation method of folic acid coupled carboxymethyl chitosan nanoparticle serving as photo-releasing NO carrier |
| 01/22/2014 | CN103520718A Drug for treating liver cancer and application of RACO-1 monoclonal antibody |
| 01/22/2014 | CN103520712A Tissue-factor-based tumor peptide vaccine as well as preparation method and application thereof |
| 01/22/2014 | CN103520710A Medicament |
| 01/22/2014 | CN103520705A Application of CD226 extracellular domain protein in inhibition of tumor cell proliferation |
| 01/22/2014 | CN103520703A Application of eIF6 in detection, prevention or treatment of exercise-induced fatigue or memory loss |
| 01/22/2014 | CN103520659A Traditional Chinese medicine for treating cancer |
| 01/22/2014 | CN103520656A Traditional Chinese medicine composition for treating pancreatic cancer |
| 01/22/2014 | CN103520653A Traditional Chinese medicine composition for treating gastric cancer |
| 01/22/2014 | CN103520652A Traditional Chinese medicine composition for treating liver cancer |
| 01/22/2014 | CN103520651A Traditional Chinese medicine composition for treating cervical cancer |
| 01/22/2014 | CN103520633A Processing method of anticancer blood-circulation activating and mass disintegrating ointment |
| 01/22/2014 | CN103520597A Traditional Chinese medicine composition for treating skin cancer |
| 01/22/2014 | CN103520596A Traditional Chinese medicine composition for treating bladder cancer |
| 01/22/2014 | CN103520571A Traditional Chinese medicine for treating qi stagnation and blood stasis syndrome type abdominal mass diseases |
| 01/22/2014 | CN103520511A Traditional Chinese medicine for treatment of blood-stagnation and phlegm-coagulation type thyroid adenomas and preparation method thereof |
| 01/22/2014 | CN103520507A Traditional Chinese medicine composition for treating thyroid cancer |
| 01/22/2014 | CN103520506A Traditional Chinese medicine composition for treating breast cancer |
| 01/22/2014 | CN103520479A Best antidote toxin-expelling medicament and preparation method thereof |
| 01/22/2014 | CN103520469A Traditional Chinese medicine for treating phlegm and qi stagnation syndrome type breast nodule diseases |
| 01/22/2014 | CN103520446A Preparing method and application of bone setting zijin pills |
| 01/22/2014 | CN103520445A Application of Tupistra chinensis in preparation of antitumor drugs |
| 01/22/2014 | CN103520430A Preparing method and application of pill containing seven drugs for kidney deficiency |
| 01/22/2014 | CN103520395A Traditional Chinese medicine composition for treating lung cancer |
| 01/22/2014 | CN103520364A Compound medicinal composition of cordyceps mycelia and preparation method thereof |
| 01/22/2014 | CN103520360A Chinese herbal compound preparation, and preparation method and application of Chinese herbal compound preparation |
| 01/22/2014 | CN103520341A Traditional Chinese medicine prescription used for treating esophageal cancer |
| 01/22/2014 | CN103520337A Traditional Chinese medicinal composition for treating liver cancer |
| 01/22/2014 | CN103520329A Traditional Chinese medicine prescription used for treating prostatic cancer |
| 01/22/2014 | CN103520324A Traditional Chinese medicine composition for treating leukemia |
| 01/22/2014 | CN103520296A Preparation method and application of purified coronary disease particle |
| 01/22/2014 | CN103520294A Preparation method for Sanhuang tablet |
| 01/22/2014 | CN103520281A Formula of biological agent for decreasing blood sugar |
| 01/22/2014 | CN103520279A Application of cinnamon extract to preparation of medicines or healthcare products for treating or preventing tumour |
| 01/22/2014 | CN103520266A Preparation method and application of pill containing Pogostemon patchouli and pulvis fellis suis |
| 01/22/2014 | CN103520263A Anti-tumor medicinal composition and preparation method thereof |
| 01/22/2014 | CN103520257A Safflower composite medicine and application thereof |
| 01/22/2014 | CN103520254A Preparation method of gypenoside nano-liposome |
| 01/22/2014 | CN103520246A Double-drug pharmaceutical composition of sweet wormwood and cantharides, and application thereof |
| 01/22/2014 | CN103520229A Application of mango extracts to preparation of anti-tumor drugs |
| 01/22/2014 | CN103520226A PH dependent type colon positioning hard capsule |
| 01/22/2014 | CN103520224A Traditional Chinese medicinal combination containing propolis and application thereof |
| 01/22/2014 | CN103520222A Cordyceps militaris extractive and application thereof in preparation of medicines for treating tumors |
| 01/22/2014 | CN103520216A Probiotic human injection |
| 01/22/2014 | CN103520208A Use of dendritic killer cell population for manufacturing medication, and pharmaceutical composition |
| 01/22/2014 | CN103520207A Targeting cisplatin sodium nano-alginate liposome |
| 01/22/2014 | CN103520198A Method for preventing tumor-induced T cell aging and reversing immunosuppression capability of tumor-induced T cell, and use of tumor-induced T cell in antitumor immunological therapy |
| 01/22/2014 | CN103520196A Capecitabine compound pharmaceutical composition |
| 01/22/2014 | CN103520195A Application of clitocine in preparation of sensitizer |
| 01/22/2014 | CN103520178A Application of compound in preparation of medicine for treating ovarian cancer |
| 01/22/2014 | CN103520177A Application of compound in preparing medicine for treating nasopharynx cancer |
| 01/22/2014 | CN103520176A Application of compound in preparing lung cancer metastasis resistance medicine |
| 01/22/2014 | CN103520175A Application of compound in preparing medicine for treating cervical cancer |
| 01/22/2014 | CN103520174A Application of compound in preparing medicine for treating bile duct cancer |
| 01/22/2014 | CN103520173A Application of compound in preparation of medicine for treating laryngeal cancer |
| 01/22/2014 | CN103520165A Application of indeno triazine compounds as substrate of quinone oxidoreductase depending on NAD (P) H |
| 01/22/2014 | CN103520159A Quinine drug-vincristine drug co-carried liposome and preparation method thereof |
| 01/22/2014 | CN103520158A Contains pioglitazone oral formulation |
| 01/22/2014 | CN103520146A Application of euphoriafactor L1 in aspect of preparation of multidrug resistance reversal agent for tumors |
| 01/22/2014 | CN103520145A Application of alternol in preparation of medicines for resisting tumor metastasis |
| 01/22/2014 | CN103520144A Application of dianhydrogalactitol in preparation of medicines for treating cervical cancer |
| 01/22/2014 | CN103520142A Application of compound in preparing medicine for treating lung cancer |
| 01/22/2014 | CN103520141A Application of compound in preparation of medicine for treating ileocecum cancer |
| 01/22/2014 | CN103520140A Application of compound in preparing medicine for treating leukemia |
| 01/22/2014 | CN103520139A Inhaled quercetin nanometer-particles and preparation method thereof |
| 01/22/2014 | CN103520135A Resveratrol-supporting poly(lactic-co-glycolic acid) micro-nano particles and preparation method thereof |
| 01/22/2014 | CN103520116A Polycaprolactone micro-nano particles loaded with resveratrol and preparation method thereof |
| 01/22/2014 | CN103520110A Method for preparing nano particles of camptothecin polymeric prodrug amphipathic molecules as well as product and application of nano particles |
| 01/22/2014 | CN103520103A Vitamin E nano-emulsion and preparation method thereof |
| 01/22/2014 | CN103520100A Etoposide self-microemulsion preparation as well as preparation method and application thereof |
| 01/22/2014 | CN103520092A Monocrotaline gel and preparation method thereof |
| 01/22/2014 | CN102940829B Traditional Chinese medicine composition for curing lung cancer |
| 01/22/2014 | CN102908626B Method for preparing chitosan/ transparent acid derivative nanofiber composite film through freezing drying technology |
| 01/22/2014 | CN102649750B Curcumin salicylic acid monoester and synthesis method thereof and application curcumin salicylic acid monoester in anti-tumor and anti-inflammatory aspects |
| 01/22/2014 | CN102491972B Carbazole derivative, preparation method thereof, and application of carbazole derivative serving as anticancer drug |
| 01/22/2014 | CN102389409B TRP-P8 active compounds and therapeutic treatment methods |
| 01/22/2014 | CN102351931B Pyrimidine nucleoside derivatives as well as synthesis method and application thereof in preparation of anti-tumor and antiviral drugs |
| 01/22/2014 | CN102302539B Method for producing trifolium pratense L. isoflavones |
| 01/22/2014 | CN102268066B Anti-HBV oligopeptides and derivatives thereof |
| 01/22/2014 | CN102124001B Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 01/22/2014 | CN102099358B Compound with serotoninergic activity, process for preparing same and pharmaceutical composition comprising same |
| 01/22/2014 | CN102070482B Derivatives of natural product S6-2, and preparation method and use thereof as anti-tumor medicines |
| 01/22/2014 | CN102026634B Induction of tumor hypoxia for cancer therapy |
| 01/22/2014 | CN101906094B Preparation and application of novel antibacterial and anticancer compound and derivative thereof |
| 01/22/2014 | CN101874817B Brucea javanica oil enteric-coated microcapsule and preparation method |
| 01/22/2014 | CN101869172B Production method of active eel peptide |
| 01/22/2014 | CN101522666B Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy |
| 01/22/2014 | CN101302192B Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP |
| 01/21/2014 | US8633236 Compounds, compositions and methods |
| 01/21/2014 | US8633224 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 01/21/2014 | US8633210 Triazole compounds useful as protein kinase inhibitors |